Cargando…
应用聚乙二醇化重组人G-CSF预防淋巴瘤患者化疗后中性粒细胞减少：一项前瞻、多中心、开放性临床研究
OBJECTIVE: To evaluate the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in prophylaxis neutropenia after chemotherapy in patients with lymphoma. METHODS: This was a multicenter, single arm, open, phase Ⅳ clinical trial. Included 410 patients...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364967/ https://www.ncbi.nlm.nih.gov/pubmed/29166732 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.001 |